Works matching IS 21644403 AND DT 2019 AND VI 9 AND IP 12
Results: 20
Calquence Receives FDA Approval for the Treatment of Patients with CLL or SLL.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 42
- Publication type:
- Article
FDA Approves Adakveo to Reduce Vaso-Occlusive Crises in Patients with Sickle-Cell Disease.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 41
- Publication type:
- Article
Brukinsa Receives FDA Approval for Patients with Mantle-Cell Lymphoma.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 41
- Publication type:
- Article
Medical Cannabis in Patients with Advanced Cancer: Challenges Remain.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 40
- By:
- Publication type:
- Article
What Is the Role of Chemoimmunotherapy in the First-Line Treatment of CLL?
- Published in:
- 2019
- By:
- Publication type:
- Proceeding
Selecting Treatment for Relapsed/Refractory Multiple Myeloma in the Era of Multiple Choices.
- Published in:
- 2019
- By:
- Publication type:
- Proceeding
CMOM-HEM/ONC Course: A Valuable Resource for Practice Managers.
- Published in:
- 2019
- Publication type:
- Interview
Sexual Health in Adolescent and Young Adult Oncology Patients.
- Published in:
- 2019
- By:
- Publication type:
- Proceeding
Preserving Sexual Function in Women After Cancer Treatment.
- Published in:
- 2019
- By:
- Publication type:
- Proceeding
Head and Neck Cancer and Sexuality in the Era of HPV: Common Questions and Answers.
- Published in:
- 2019
- By:
- Publication type:
- Proceeding
Neurofeedback Reduces Symptoms of CIPN.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 24
- By:
- Publication type:
- Article
Pemigatinib Effective in Patients with Cholangiocarcinoma and FGFR2 Fusion or Rearrangement.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 22
- By:
- Publication type:
- Article
Practice-Changing Results: Ivosidenib First Targeted Therapy to Show Benefits in Patients with Cholangiocarcinoma and IDH1 Mutation.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 21
- By:
- Publication type:
- Article
Observation Postsurgery Better Than Radiotherapy in Men with Prostate Cancer: Use Early Salvage Radiotherapy with PSA Rise.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 19
- By:
- Publication type:
- Article
Ceritinib Effective in Treating Brain Metastases in NSCLC.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 18
- By:
- Publication type:
- Article
Olaparib Improves Outcomes in Metastatic CRPC with Gene Mutations: The Era of Targeted Therapy in Prostate Cancer Is Here.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 15
- By:
- Publication type:
- Article
This Is Cancer: The Changing Face of the Patient Experience.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 9
- By:
- Publication type:
- Article
Paradigm Shift: PARP Inhibitors Should Be Offered to All Patients with Ovarian Cancer.
- Published in:
- 2019
- By:
- Publication type:
- Conference Paper/Materials
Results Not Typical: The Relationship Between Privilege and Clinical Trials.
- Published in:
- 2019
- By:
- Publication type:
- Proceeding
How to Avoid Being Blindsided in 2020.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 12, p. 1
- By:
- Publication type:
- Article